SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.66 |
| Enterprise Value ($M) | 6.52 |
| Book Value ($M) | 1.37 |
| Book Value / Share | 0.61 |
| Price / Book | 3.41 |
| NCAV ($M) | 1.36 |
| NCAV / Share | 0.60 |
| Price / NCAV | 3.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.93 |
| Return on Assets (ROA) | -0.76 |
| Return on Equity (ROE) | -0.81 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.13 |
| Current Ratio | 5.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.69 |
| Assets | 1.70 |
| Liabilities | 0.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 7,505 | 26,787 | 28.02 | |
| 33,901 | 109,768 | 30.88 | |
| 13,041 | 27,559 | 47.32 | |
| 3,745 | 26,925 | 13.91 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LFVN – LifeVantage Corporation | LGVN – Longeveron Inc. |
| LIPO – Lipella Pharmaceuticals Inc. | LPCN – Lipocine Inc. |
| LPTX – Leap Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io